Join
Live feed
·
INSIDERFilingvia Quantisnow
C4 Therapeutics Inc. logo

Chief Accounting Officer Mossler Mark was granted 56,980 shares, converted options into 9,420 shares and covered exercise/tax liability with 3,268 shares, increasing direct ownership by 295% to 71,916 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CCCC (C4 Therapeutics Inc.) and more on Quantisnow.